• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
BiOSS® Clinical Programme - State of the Art - BiOSS LIM® Stent - The Novel Option for Coronary Bifurcation Treatment.BiOSS®临床项目——最新技术——BiOSS LIM®支架——冠状动脉分叉病变治疗的新选择。
Interv Cardiol. 2015 May;10(Suppl 1):3-6. doi: 10.15420/icr.2015.10.2.S1.
2
Dedicated Bifurcation Drug-eluting Stent BiOSS® - A Novel Device for Coronary Bifurcation Treatment.专用分叉药物洗脱支架BiOSS®——一种用于冠状动脉分叉病变治疗的新型器械。
Interv Cardiol. 2013 Mar;8(1):19-22. doi: 10.15420/icr.2013.8.1.19.
3
First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results.紫杉醇洗脱支架 BiOSS(分叉优化支架系统)治疗冠状动脉分叉病变的首例人体研究:三个月结果。
Kardiol Pol. 2012;70(1):45-52.
4
BiOSS LIM C: thin-strut cobalt-chromium version of the dedicated bifurcation stent.BiOSS LIM C:专用分叉支架的薄壁钴铬版本。
Expert Rev Med Devices. 2017 Apr;14(4):279-284. doi: 10.1080/17434440.2017.1318058. Epub 2017 Apr 19.
5
First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C® - three-month results.首例专用分叉钴铬依维莫司洗脱支架 BiOSS LIM C® 的人体研究 - 三个月结果。
Kardiol Pol. 2018;76(2):464-470. doi: 10.5603/KP.a2017.0226. Epub 2017 Dec 1.
6
12-month intravascular ultrasound observations from BiOSS® first-in-man studies.来自BiOSS®人体首次研究的12个月血管内超声观察结果。
Int J Cardiovasc Imaging. 2016 Sep;32(9):1339-1347. doi: 10.1007/s10554-016-0926-9. Epub 2016 Jun 17.
7
Comparative analysis of lumen enlargement mechanisms achieved with the bifurcation dedicated BiOSS) stent versus classical coronary stent implantations by means of provisional side branch stenting strategy: an intravascular ultrasound study.分叉专用支架(BiOSS)与经典冠状动脉支架置入术经预开窗边支技术治疗后管腔扩张机制的对比分析:血管内超声研究。
Int J Cardiovasc Imaging. 2013 Dec;29(8):1667-76. doi: 10.1007/s10554-013-0264-0. Epub 2013 Jul 19.
8
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial.普通药物洗脱支架与专用冠状动脉分叉西罗莫司洗脱BiOSS LIM®支架对比:随机、多中心、开放标签、对照的POLBOS II试验
EuroIntervention. 2016 Dec 10;12(11):e1404-e1412. doi: 10.4244/EIJY15M11_11.
9
First-in-man study of dedicated bifurcation sirolimus-eluting stent: 12-month results of BiOSS LIM® Registry.专用分叉西罗莫司洗脱支架的首次人体研究:BiOSS LIM® 注册研究的 12 个月结果。
J Interv Cardiol. 2015 Feb;28(1):51-60. doi: 10.1111/joic.12180.
10
Sirolimus-eluting BiOSS LIM dedicated bifurcation stent in the treatment of unprotected distal left main stenosis.西罗莫司洗脱生物可吸收血管支架系统治疗无保护左主干远端狭窄
Catheter Cardiovasc Interv. 2019 Sep 1;94(3):323-331. doi: 10.1002/ccd.28132. Epub 2019 Feb 17.

本文引用的文献

1
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry.雷帕霉素靶向洗脱生物可吸收支架治疗左主干远端狭窄的长期有效性和安全性:国际注册研究。
EuroIntervention. 2016 Nov 20;12(10):1246-1254. doi: 10.4244/EIJY15M10_05.
2
Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I Trial.普通药物洗脱支架与专用冠状动脉分叉BiOSS专家支架对比:多中心开放标签随机对照POLBOS I试验
Can J Cardiol. 2015 May;31(5):671-8. doi: 10.1016/j.cjca.2014.12.024. Epub 2014 Dec 24.
3
First-in-man study of dedicated bifurcation sirolimus-eluting stent: 12-month results of BiOSS LIM® Registry.专用分叉西罗莫司洗脱支架的首次人体研究:BiOSS LIM® 注册研究的 12 个月结果。
J Interv Cardiol. 2015 Feb;28(1):51-60. doi: 10.1111/joic.12180.
4
Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings.冠状动脉分叉病变的经皮冠状动脉介入治疗:欧洲分叉俱乐部会议头10年的共识
EuroIntervention. 2014 Sep;10(5):545-60. doi: 10.4244/EIJV10I5A97.
5
Double bifurcation optimization stent system technique for left main stenosis.
J Interv Cardiol. 2014 Dec;27(6):570-3. doi: 10.1111/joic.12155. Epub 2014 Sep 16.
6
Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert® in the treatment of distal left main stem stenosis.专用分叉紫杉醇洗脱支架BiOSS Expert®治疗左主干远端狭窄
J Interv Cardiol. 2014 Jun;27(3):242-51. doi: 10.1111/joic.12119. Epub 2014 Apr 7.
7
Stenting below-the-knee bifurcations with dedicated bifurcation stent BiOSS Lim - first in man case report.
Cardiovasc Revasc Med. 2014 Apr;15(3):171-7. doi: 10.1016/j.carrev.2013.09.005. Epub 2013 Oct 22.
8
Comparative analysis of lumen enlargement mechanisms achieved with the bifurcation dedicated BiOSS) stent versus classical coronary stent implantations by means of provisional side branch stenting strategy: an intravascular ultrasound study.分叉专用支架(BiOSS)与经典冠状动脉支架置入术经预开窗边支技术治疗后管腔扩张机制的对比分析:血管内超声研究。
Int J Cardiovasc Imaging. 2013 Dec;29(8):1667-76. doi: 10.1007/s10554-013-0264-0. Epub 2013 Jul 19.
9
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population.专用紫杉醇洗脱分叉支架 BiOSS®(分叉优化支架系统):前瞻性连续全人群注册研究的 12 个月结果。
EuroIntervention. 2012 Jul 20;8(3):316-24. doi: 10.4244/EIJV8I3A50.
10
Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model.带有雷帕霉素洗脱的分叉优化支架系统(BiOSS Lim):来自猪冠状动脉模型的结果。
EuroIntervention. 2011 Sep;7(5):614-20. doi: 10.4244/EIJV7I5A98.

BiOSS®临床项目——最新技术——BiOSS LIM®支架——冠状动脉分叉病变治疗的新选择。

BiOSS® Clinical Programme - State of the Art - BiOSS LIM® Stent - The Novel Option for Coronary Bifurcation Treatment.

作者信息

Bil Jacek, Gil Robert J, Vassilev Dobrin

机构信息

Department of Invasive Cardiology, Central Clinical Hospital of the Ministry of Interior Warsaw, Poland.

Institute of Experimental and Clinical Medicine, Polish Academy of Science Warsaw, Poland.

出版信息

Interv Cardiol. 2015 May;10(Suppl 1):3-6. doi: 10.15420/icr.2015.10.2.S1.

DOI:10.15420/icr.2015.10.2.S1
PMID:40337744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12054335/
Abstract

The BiOSS LIM® (Bifurcation Optimization Stent System, Balton, Warsaw, Poland) stent is a coronary, dedicated bifurcation, balloonexpandable stent made of 316 L stainless steel with a strut thickness of 120 μm. It is covered with a mixture of a biodegradable polymer and the antiproliferative substance: sirolimus. The stent consists of two parts (the proximal with a larger diameter in relation to the distal one) connected with two struts (average 1.5 mm length) at the middle zone. The stent is crimped on a bottle-shaped semi-compliant balloon (Bottle®, Balton, Warsaw, Poland). Our intravascular ultrasound (IVUS) study revealed that the construction of the BiOSS® stent allows easy access to the side branch, similar to the classic stent lumen enlargement with less injury to the area adjacent to the most sensitive part of the bifurcation. The BiOSS LIM® stent has already been thoroughly investigated: initially in the First-In-Man registry with 60 patients, then in the registry in a high-risk population with distal left main stenosis and finally in a randomised clinical trial POLBOS II. The long-term clinical results were satisfactory and closely related to the high-risk profile of the treated population. Our data demonstrated that the simple and fast bifurcation treatment with a single dedicated bifurcation sirolimus-eluting stent (BiOSS LIM®) is feasible and highly successful.

摘要

BiOSS LIM®(分叉优化支架系统,Balton,华沙,波兰)支架是一种冠状动脉专用分叉球囊扩张支架,由316L不锈钢制成,支柱厚度为120μm。它覆盖有可生物降解聚合物和抗增殖物质西罗莫司的混合物。该支架由两部分组成(近端直径相对于远端更大),在中间区域通过两个支柱(平均长度1.5mm)连接。该支架被压握在瓶形半顺应性球囊(Bottle®,Balton,华沙,波兰)上。我们的血管内超声(IVUS)研究表明,BiOSS®支架的结构便于进入侧支,类似于经典的支架管腔扩大,对分叉最敏感部位附近区域的损伤较小。BiOSS LIM®支架已经经过了充分研究:最初在60例患者的首次人体注册研究中,然后在远端左主干狭窄的高危人群注册研究中,最后在随机临床试验POLBOS II中。长期临床结果令人满意,并且与所治疗人群的高危特征密切相关。我们的数据表明,使用单一专用分叉西罗莫司洗脱支架(BiOSS LIM®)进行简单快速的分叉治疗是可行且非常成功的。